Early studies suggest a high systemic score (>10) correlates with increased risk of aortic root surgery and scoliosis progression. Meanwhile, a low score (<5) in a confirmed FBN1 mutation carrier predicts a milder course—often called "non-syndromic" FBN1 disease.
This is not a simple number like a blood pressure reading. It is a —a weighted checklist that aggregates subtle clinical findings. When combined with family history and genetic testing, this score is the linchpin of the Revised Ghent Nosology , the international standard for diagnosis. marfan syndrome score
The next generation of scores may integrate (blood levels of TGF-beta) and aortic Z-score trajectories (how fast the aorta grows per year). But for now, the bedside physical exam remains king. Conclusion: More Than a Number The Marfan Syndrome Score is not a grade on a test. It is a diagnostic compass . It tells the cardiologist when to order an annual echo. It tells the orthopedist when to brace the spine. And it tells the patient, after years of being called "just lanky," that their constellation of features has a name. Early studies suggest a high systemic score (>10)